Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Frederick Hayden and Ghaleb Al Mekhlafi.
Frederick Hayden
Connection Strength
0.261
Ghaleb Al Mekhlafi
  1. Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome. N Engl J Med. 2020 10 22; 383(17):1645-1656.
    View in: PubMed
    Score: 0.057
  2. Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study. Clin Infect Dis. 2020 04 15; 70(9):1837-1844.
    View in: PubMed
    Score: 0.055
  3. Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-ß1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial. Trials. 2020 Jan 03; 21(1):8.
    View in: PubMed
    Score: 0.054
  4. Critically ill healthcare workers with the middle east respiratory syndrome (MERS): A multicenter study. PLoS One. 2018; 13(11):e0206831.
    View in: PubMed
    Score: 0.050
  5. Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study. Crit Care Med. 2017 10; 45(10):1683-1695.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.